Cancer biotech gets another new name (now it’s called Xilio) - STAT

Cancer biotech gets another new name (now it’s called Xilio) - STAT

STAT Plus: Cancer biotech gets another new name (now it’s called Xilio) and more than $100 million

By JONATHAN SALTZMAN — BOSTON GLOBE

ARSANIS

For the second time in less than two years, Akrevia Therapeutics has changed its name and raised $100 million in additional venture capital.

READ MORE